Secondary Logo

Institutional members access full text with Ovid®

Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Upper Face

de Maio, Maurício, M.D.; Swift, Arthur, M.D.; Signorini, Massimo, M.D.; Fagien, Steven, M.D.; On behalf of the Aesthetic Leaders in Facial Aesthetics Consensus Committee


In the August 2017 Cosmetic article by de Maio et al. entitled “Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Upper Face” ( Plast Reconstr Surg . 2017;140:265e–276e), a degree listed in the second sentence of the Acknowledgments section is incorrect. The sentence should have read as follows (correction in italics ): Medical writing assistance was provided by Barry Weichman, Ph.D. , of Peloton Advantage, Parsippany, New Jersey, and funded by Allergan plc, Dublin, Ireland.

Plastic and Reconstructive Surgery. 140(4):867-868, October 2017.

Plastic and Reconstructive Surgery: August 2017 - Volume 140 - Issue 2 - p 265e-276e
doi: 10.1097/PRS.0000000000003544
Cosmetic: Original Articles

Summary: Techniques for the administration of injectable fillers and neuromodulators for facial aesthetic rejuvenation and enhancement continue to evolve. As the number of physicians with limited experience in providing aesthetic treatments expands, the need for guidance and training from more experienced injectors has become apparent. The use of a slow, careful, and methodical injection technique is imperative in all treatment settings and for all facial areas. Constant attention to local anatomy, particularly arteries, veins, and nerve bundles, is critical for minimizing complications. This first article of a three-part series addresses techniques and recommendations for aesthetic treatment of the upper face. Traditionally, the upper face has been considered a basic area for treatment with neuromodulators but an advanced area for treatment with fillers. Injectable fillers may be used for temple volumization, eyebrow shaping, and forehead contouring. Neuromodulators are well suited for diminishing the appearance of dynamic facial lines such as forehead, glabellar, and crow’s feet lines, and eyebrow lifting and eye-aperture widening. These techniques may be used independently or together, sequentially or concurrently, to address rejuvenation of individual or multiple facial regions. Overall, this series provides a practical framework of techniques for physicians who desire to perform safe and effective aesthetic treatments using a multimodal approach.

São Paulo, Brazil; Montreal, Quebec, Canada; Milan, Italy; and Boca Raton, Fla.

From the Clinica Dr. Maurício de Maio; The Westmount Institute of Plastic Surgery; Istituto Dermatologico Europeo; and Aesthetic Eyelid Plastic Surgery.

Received for publication March 15, 2016; accepted February 10, 2017.

Disclosure:Dr. de Maio is an Allergan plc consultant for speaking events and marketing strategy. Dr. Signorini has no conflicts to disclose. Dr Swift is a consultant, advisory board member, clinical investigator and speaker for Allergan, Galderma, and Merz. Dr. Fagien is an Allergan plc and Galderma consultant for the speakers bureau, and is on the advisory board and is a clinical investigator for Allergan plc and Galderma.

Maurício de Maio, M.D., Clinica Dr. Maurício de Maio, Avenida Ibirapuera, 2907 cj 1202, Moema EP: 04029200, São Paulo, Brazil,

Copyright © 2017 by the American Society of Plastic Surgeons